HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
J A Engelman Selected Research
J A Engelman Research Topics
Disease
5
Neoplasms (Cancer)
11/2017 - 10/2000
2
Lung Neoplasms (Lung Cancer)
11/2017 - 04/2010
2
Colorectal Neoplasms (Colorectal Cancer)
11/2017 - 09/2010
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2013 - 12/2011
1
Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
06/2001
1
Cachexia
10/2000
1
Insulin Resistance
10/2000
1
Obesity
10/2000
1
Bacterial Infections (Bacterial Infection)
10/2000
1
Carcinogenesis
02/2000
Drug/Important Bio-Agent (IBA)
2
Phosphotransferases (Kinase)
IBA
04/2010 - 10/2000
1
SAR405838
IBA
11/2017
1
N- (2,3- dihydroxypropyl)- 1- ((2- fluoro- 4- iodophenyl)amino)isonicotinamide
IBA
11/2017
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
11/2017
1
Pemetrexed (MTA)
FDA Link
01/2013
1
Crizotinib
IBA
01/2013
1
Anaplastic Lymphoma Kinase
IBA
01/2013
1
AMP-Activated Protein Kinases
IBA
09/2010
1
dacomitinib
IBA
04/2010
1
Gefitinib (Iressa)
FDA Link
04/2010
1
ErbB Receptors (EGF Receptor)
IBA
04/2010
1
Tyrosine Kinase Inhibitors
IBA
04/2010
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
04/2010
1
Caveolin 3
IBA
06/2001
1
Serine (L-Serine)
FDA Link
10/2000
1
Insulin (Novolin)
FDA Link
10/2000
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
10/2000
1
Tyrosine (L-Tyrosine)
FDA Link
10/2000
1
Insulin Receptor Substrate Proteins
IBA
10/2000
1
Proteins (Proteins, Gene)
FDA Link
02/2000
Therapy/Procedure
3
Therapeutics
11/2017 - 04/2010
1
Drug Therapy (Chemotherapy)
01/2013